McKesson shared a post on LinkedIn:
“Join us and Endpoints News for a virtual panel discussion at The 2025 ASCO Annual Meeting.
We will explore the impact of technology on precision medicine in community oncology practices, and how digital transformation can seamlessly integrate precision medicine into daily workflows.
Hear from industry experts and patient advocates as they share insights and practical steps to advance precision medicine access and delivery that improve patient care and outcomes.
Register for the panel.”
Sarah Cannon Research Institute shared this post, adding:
“Dr. Andrew McKenzie, Vice President, Personalized Medicine for SCRI and Scientific Director for Genospace, will take part in this important panel discussing the latest advancements in personalized medicine for community practices.
Be sure to tune in to this virtual discussion at ASCO25.”
More posts featuring ASCO25.